The editors are publishing this note to alert readers to concerns about this article (1). In Fig. 2, the actin loading control bands for cyclin D1 and cyclin D2 are identical–the authors clarified that the Western blots for cyclin D1 and cyclin D2 were performed on the same samples, however, this was not indicated in the figure legend. Additionally, in Fig. 6C, the p-EGFR bands in MDA-MB-231 cells showing stimulation by TGFα treatment are identical to the p-EGFR bands showing stimulation by EGF treatment. In the original submission of this manuscript, a correct version of this figure was used to show both TGFα and EGF could stimulate p-EGFR in control vector (CTR)– and MT4-MMP–expressing (MT4) MDA-MB-231 cells, but these panels were mistakenly duplicated in the revised and final versions of the manuscript.
Skip Nav Destination
Article navigation
Editor's Note|
February 15 2022
Editor's Note: EGFR Activation and Signaling in Cancer Cells Are Enhanced by the Membrane-Bound Metalloprotease MT4-MMP Free
Cancer Res 2022;82:734
Online ISSN: 1538-7445
Print ISSN: 0008-5472
©2022 American Association for Cancer Research
2022
American Association for Cancer Research
Cancer Res (2022) 82 (4): 734.
Related Content
- Split-Screen
- Views Icon Views Open Menu
- Open the PDF for in another window
- Share Icon Share
-
Tools Icon
Tools
Open Menu
- Search Site
-
Article Versions Icon
Versions
- Version of Record February 15 2022
Citation
Alexandra Paye, Alice Truong, Cassandre Yip, Jonathan Cimino, Silvia Blacher, Carine Munaut, Didier Cataldo, Jean Michel Foidart, Erik Maquoi, Joelle Collignon, Philippe Delvenne, Guy Jerusalem, Agnes Noèl, Nor Eddine Sounni; Editor's Note: EGFR Activation and Signaling in Cancer Cells Are Enhanced by the Membrane-Bound Metalloprotease MT4-MMP. Cancer Res 15 February 2022; 82 (4): 734. https://doi.org/10.1158/0008-5472.CAN-21-4292
Download citation file:
Advertisement
1,280
Views